CORDiguide
AI Technology for Navigating the Catheter in Cardiological and Cerebral Interventions
Company Overview
Snapshot
Founded in January 2021 by Yehoshua (Josh) Zeevi and Rafael Beyar, CORDiguide operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing AI-based technology for medical interventions. In March 2021, CORDiguide was announced as a medical spin-off from Cortica, highlighting its strategic origin in autonomous AI technology.
Business overview
CORDiguide develops AI-based technology designed for the real-time guidance and navigation of catheters during cardiological and cerebral interventional procedures. Its core technology utilizes artificial intelligence to localize the treatment of cancerous tissues by guiding miniature devices, such as stents, along blood vessels to the target area. The company operates within the Health Tech & Life Sciences sector, specifically targeting the Digital Healthcare and Medical Decision Support markets, serving healthcare providers.
Strategic signal
In March 2021, CORDiguide was announced as a medical spin-off of Cortica's autonomous AI technology. This signals a strategic move to apply advanced AI capabilities from a broader technology company to specialized medical applications, indicating a strong foundation in AI development and a clear focus on innovation within interventional cardiology and neurology.
Log in to access full profile ›Company Intelligence Q&A
- What is CORDiguide's primary focus?
- CORDiguide focuses on developing AI-based technology for the real-time guidance and navigation of catheters in cardiological and cerebral interventional procedures performed under angiographic imaging.
- When was CORDiguide founded?
- CORDiguide was founded in January 2021.
- Who are the co-founders of CORDiguide?
- Yehoshua (Josh) Zeevi and Rafael Beyar are the co-founders of CORDiguide.
- What significant corporate development occurred in March 2021?
- In March 2021, Cortica announced CORDiguide as a medical spin-off, leveraging its autonomous AI technology for medical applications.
- Which sector does CORDiguide primarily operate in?
- CORDiguide primarily operates in the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Medical Decision Support.